Patients who raised aod-9604 for gut health with their provider proactively reported better outcomes than those who waited until it became a problem
Patients at highest risk include those in the dose-escalation phase, experiencing active gastrointestinal symptoms (nausea, vomiting, bloating), those with known gastroparesis, or those taking concurrent medications that further delay gastric emptying (such as opioids)
Wegovy works similarly to Ozempic by acting on GLP-1 receptors to regulate appetite
NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimers diseases
Using semaglutide that has gone bad or has been improperly stored can put your health at risk
January 6, 2026: The GLP-1 MDL, which includes claims for Ozempic, now has over 3,000 cases pending in federal court